🔎 Trials Near Me

Akèy › Kansè lestomak › Arizona

Etid klinik pou Kansè lestomak nan Arizona

13 etid pou Kansè lestomak ap chèche patisipan nan sit nan Arizona.

Vil nan Arizona

Tèks ofisyèl etid la (Anglè)

Studying the PAGODA Algorithm for Chemotherapy Dose Changes to Prevent Unplanned Treatment Delays

  • Cancer Center at Saint Joseph's, Phoenix
Ap rekriteVolontè an sante akeyi
Laj 18 ak plis · Tout sèks · Mizajou Oct 2, 2026 · NCT07283939

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

  • Kingman Regional Medical Center, Kingman
  • Cancer Center at Saint Joseph's, Phoenix
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Laj 40 a 75 · Tout sèks · Mizajou Oct 2, 2026 · NCT05334069

A Study of SHY-ONC6, a Novel Proteasome Inhibitor, in Adults With Advanced or Metastatic Solid Tumors

  • HonorHealth Research Institute, Scottsdale
Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Sep 18, 2026 · NCT07705334

Study of Orally Administered MOMA-341 in Participants With Advanced or Metastatic Solid Tumors

  • Investigative Site #132, Phoenix
Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Jul 23, 2026 · NCT06974110

A Study of SGN-CEACAM5C in Adults With Advanced Solid Tumors

  • Mayo Clinic Hospital, Phoenix
  • Mayo Clinic, Scottsdale
Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Jul 22, 2026 · NCT06131840

Givastomig Combined With Nivolumab and Chemotherapy in Adults With CLDN18.2 Positive Metastatic Gastric Cancer (GIVA-2)

  • I-Mab Site 1016, Goodyear
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou May 14, 2026 · NCT07432295

A Study of PARG Inhibitor ETX-19477 in Patients With Advanced Solid Malignancies

  • Mayo Clinic, Phoenix
Ap rekriteFaz 1/2
Laj 18 ak plis · Tout sèks · Mizajou Mar 27, 2026 · NCT06395519

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

  • Massive Bio SYNERGY-AI site, Scottsdale
Ap rekriteEtid obsèvasyon
Tout laj · Tout sèks · Mizajou Oct 28, 2025 · NCT03452774

Study of CRX100 as Monotherapy and in Combination With Pembrolizumab in Patients With Advanced Solid Malignancies

  • HonorHealth Research Institute, Scottsdale
Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Feb 8, 2024 · NCT04282044

Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.